Month: May 2024

Tapestry's Eric Chavous Selected for Minority Corporate Counsel Association’s 2024 Sources of Success™ Program

Posted on by

Tapestry congratulates Eric Chavous, Senior Manager and Counsel at Tapestry on his acceptance into the Minority Corporate Counsel Association’s 2024 Sources of Success™ Program. A highly competitive professional development program that accepts about 30 attorneys from legal departments and law firms across the U.S. each year, MCCA’s Sources of Success Program is designed to help mid-career attorneys excel as leaders within their organizations. Each year, the curriculum evolves to address the needs of the cohort to excel as leaders within their own organizations.

Tapestry is proud that Eric has been recognized and selected to be a part of this esteemed program, and we look forward to seeing him reach even further heights.

We connected with Eric, and he shared a little about his experience at Tapestry:

Q: Can you share your role, how long you’ve been at Tapestry and a few details about what your team oversees? I am Sr. Manager, Counsel and have worked at Tapestry for a little over three years. I started as an independent contractor and was converted to full-time nearly three years ago. Currently, I support both the Contracts team that oversees all agreements entered across Tapestry and its brands in NA, and the Intellectual Property team responsible for managing Tapestry’s global IP portfolio and clearing designs, artwork, and names for brand design and merchandise teams.

Q: What is your proudest moment/achievement at Tapestry? I am blessed to be able to truthfully say I have had numerous proud moments at Tapestry. The moment that sticks out the most at this time is the opportunity I had to give a presentation on NFTs to our Executive Committee with one of my colleagues. Not many lawyers at my career level can claim they have personally presented to the entire Executive Committee of a multi-billion dollar public company.

Q: What words would you use to describe our culture? Innovative. Fast. Inclusive.

 

Learn more about Tapestry and how we support our people to achieve their professional goals here.

Posted in UncategorizedTagged

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress

Posted on by

Patients receiving nine-dose regimen over five months experienced deep and durable reduction in proteinuria, reaching up to ~50% mean reduction in UPCR at end of study at month 24 and over 18 months after last dose Patients across treatment arms exhibited stabilization in eGFR through 24…

Posted in UncategorizedTagged

61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

Posted on by

STOCKHOLM, May 24, 2024 /PRNewswire/ — A pioneering study, presented today at the 61st ERA Congress, has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.